Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Revive Therapeutics Ltd
C.RVV
Alternate Symbol(s):
RVVTF
Healthcare
Revive Therapeutics Ltd. is a Canada-based life sciences company. The Company is focused on the research and development of therapeutics and diagnostics for infectious diseases, medical countermeasures, and rare disorders. It is engaged in exploring the use of Bucillamine for the potential treatment of nerve agent exposure and long COVID. The Company, through its diagnostics division, is...
evaluating a point-of-care in vitro diagnostic device that aids in the detection of post COVID-19 conditions or Long COVID. It also advancing the development of Psilocybin-based therapeutics through various programs. The Company's subsidiaries include Revive Therapeutics Inc. (Ontario), Revive Diagnostics Inc., and Psilocin Pharma Corp. (Ontario).
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Company Website
Add To Watchlist
Bullboard (CSE:RVV)
New Post
View:
Posts & Comments
Threaded Posts
Prev
...
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
...
Next
(5)
•••
cool888
X
View Profile
View Bullboard History
Post by
cool888
on Jun 22, 2022 6:46pm
Excerpt from Famotidine Study regarding Endpoints Analysis
#Bucillamine https://www.reddit.com/r/RVVTF/comments/vifv02/excerpt_from_famotidine_study_regarding_endpoints/
(5)
•••
cool888
X
View Profile
View Bullboard History
Post by
cool888
on Jun 21, 2022 5:13pm
More vulnerable people receiving fewer COVID pills !
#Bucillamine - The World need this one very, very soon !! June 21 (Reuters) - People in socially and economically disadvantaged regions are about half as likely to receive an oral antiviral COVID
...more
(5)
•••
cool888
X
View Profile
View Bullboard History
Post by
cool888
on Jun 19, 2022 1:16pm
Israel sees 70% spike in number of seriously ill COVID ...
#Bucillamine https://www.timesofisrael.com/israel-sees-sharp-70-jump-in-number-of-seriously-ill-covid-patients-within-a-week/
(5)
•••
cool888
X
View Profile
View Bullboard History
Post by
cool888
on Jun 17, 2022 4:44pm
Early Omicron infection unlikely to protect against current
#Bucillamine https://nationalpost.com/pmn/health-pmn/early-omicron-infection-unlikely-to-protect-against-current-variants
(5)
•••
cool888
X
View Profile
View Bullboard History
Post by
cool888
on Jun 17, 2022 7:05am
Waiting for Bucillamine Trial Results ...
#Bucillamine https://www.reddit.com/r/RVVTF/comments/vdweva/waiting_for_bucillamine_trial_results/
(5)
•••
cool888
X
View Profile
View Bullboard History
Post by
cool888
on Jun 15, 2022 8:31pm
Interesting Video - How Big Pharma pushes dangerous drugs ..
Nothing to do with $RVV, of course ! https://www.youtube.com/watch?v=XCciAJJMt9Q
(5)
•••
cool888
X
View Profile
View Bullboard History
Post by
cool888
on Jun 15, 2022 8:21pm
$RVV - Buci Video ! Folks - Days are getting closer & closer
#Bucillamine https://youtu.be/gnoGOeHu6UA
(5)
•••
cool888
X
View Profile
View Bullboard History
Post by
cool888
on Jun 15, 2022 3:12pm
Fauci tests positive for Covid-19
#Bucillamine He has been boosted twice !
(7)
•••
90guppy
X
View Profile
View Bullboard History
Comment by
90guppy
on Jun 15, 2022 9:03am
RE:TDR Tweet ..
Oh yeah!
(5)
•••
cool888
X
View Profile
View Bullboard History
Post by
cool888
on Jun 15, 2022 6:22am
TDR Tweet ..
This is potentially big news for $RVVTF. Pfizer just stopped their trial for standard risk patients for Paxlovid for COVID treatment. The data showed no improvement. Door wide open for Revive to
...more
(5)
•••
cool888
X
View Profile
View Bullboard History
Post by
cool888
on Jun 14, 2022 5:08pm
Pfizer stops enrollment in Paxlovid trial in standard-risk..
#Bucillamine https://www.cnbc.com/2022/06/14/pfizer-stops-enrollment-in-covid-antiviral-trial-in-standard-risk-population-.html
(5)
•••
cool888
X
View Profile
View Bullboard History
Post by
cool888
on Jun 13, 2022 8:48pm
FDA Wake UP IDITOS !! - TIME to EUA #Bucillamine
#Bucillamine L.A. County coronavirus cases, hospitalizations rising again, dashing hopes surge has crested https://www.latimes.com/california/story/2022-06-10/l-a-county-coronavirus-cases-covid
...more
(120)
•••
ENEMENEMYNEMO
X
View Profile
View Bullboard History
Post by
ENEMENEMYNEMO
on Jun 11, 2022 8:45am
Just in case
If BUC fails we got this too! https://www.cnn.com/2022/06/11/health/psilocybin-brain-changes-life-itself-wellness-scn/index.html
(5)
•••
cool888
X
View Profile
View Bullboard History
Post by
cool888
on Jun 10, 2022 8:30pm
The Virus Is Still Winning ! Bucillamine to the WORLD !!
#Bucillamine It's Time Folks !! https://www.project-syndicate.org/commentary/covid-19-vaccines-not-enough-need-new-antivirals-by-william-a-haseltine-2022-06?utm_source=facebook&utm_medium
...more
(120)
•••
ENEMENEMYNEMO
X
View Profile
View Bullboard History
Comment by
ENEMENEMYNEMO
on Jun 08, 2022 6:09pm
RE:Level 2 this morning
Trying to force a sell-off to grab more... they kept pulling the ask when things got close... didn't work suckers.... obviously people are seeing good things to come. Raymond James hire
...more
Prev
...
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
This $10M Deal Could Reshape the Future of Global Creator Platforms
New Gold and Copper Hotspot Identified – What’s Next for This Serbian Project?
Major Funding Secured! Company Closes First Round of Private Placement